Minovia Therapeutics’ Collaboration and License Agreement with Astellas Pharma

Martina Bellini
Tagged:

Goodwin Procter advised Minovia Therapeutics on the deal.Minovia Therapeutics announced its worldwide strategic collaboration and license agreement with Astellas Pharma (TSE: 4503) to research, develop, and commercialize…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

…

This content is for Standard 1 Year members only.
Login Join Now